Otolaryngology and Head & Neck Surgery Journal of the American Medical Association
-
June 1, 2026
Original Source(s)
Related Content
AI Scribes: Efficiency for Whom?
Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.
January 27, 2026
-
3 min
Outreach screening may uncover hearing loss
Recommended treatment was implemented in only about one-third of traceable cases, leaving substantial hearing care gaps after detection.
August 25, 2026
-
5 min
FDA Okays Weekly Option in Achondroplasia
Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.
March 2, 2026
-
2 min
